Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tolonium chloride is a cationic phenothiazine dye used primarily as a histological stain and as a diagnostic vital dye, with high affinity for acidic tissue components such as nucleic acids (DNA and RNA) due to electrostatic interactions, enabling selective staining of dysplastic or malignant mucosa and other tissues rich in nucleic acids.[2][4] It has been used clinically as an adjunctive diagnostic aid for oral and gastric neoplasms and to help identify parathyroid glands during thyroid surgery; it has also been explored as a photosensitizer in antimicrobial photodynamic therapy in periodontal disease.[1][2][6] Mechanistically, it binds to polyanionic macromolecules (DNA/RNA) and can act as a fluorochrome/metachromatic dye; under light activation (e.g., 635 nm), it generates reactive oxygen species for photodynamic effects.[1][2][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tolonium chloride.